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ABSTRACT
The patient was a 15 year-old girl who turned out at the Physical Therapy Clinic presenting progressive
scoliosis and angle of 50º Coob by X-Ray. She complained of back pain, headache and weakness of
shoulder and pelvic girdle. Physical therapy evaluation came across features of delayed motor develop-
ment and undernourishment, together with generalized muscle weakness (grade = 4) which was ob-
served by the Kendall test. Lung vital capacity was 40.5%. Clinical Changes: studies of the enzymes with
acid alpha-glucosidase assay kits used on filter paper and leukocytes showed low enzyme activity,
suggesting a late form of the Pompe disease. The molecular studies proved that the patient had a
mutation associated with late-onset Pompe disease. Acid alpha-glucosidase enzyme assay studies
performed in skin fibroblasts showed a reduction of the enzymatic activity of the acid alpha-glucosidase,
confirming the previous results. On account of the results, Pompe disease induced important changes in
clinical and functional, as well as metabolic changes, decreased strength and muscle action potentially,
biomechanical changes in the spine and changes in respiratory capacity. Furthermore, this case of
Pompe disease illustrates the importance of adequate physical therapy evaluation as it can be the
starting point of investigation of serious conditions such as late onset Pompe disease.
Keywords: Musculoskeletal Abnormalities. Glycogen Storage Disease. Glycogen Storage Disease Type
II. Biomechanics. Scoliosis.
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Introduction
Pompe disease is a rare autosomal recessive
myopathy caused by a deficiency of acid alpha-glu-
cosidase enzyme, leading to an intracellular accumu-
lation of glycogen, particularly affecting the myocar-
dium, the skeletal muscle and the liver. The rupture of
lysosomes results in cellular disfunction, abnormal au-
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tophagy and structural disorganization with primarily
symptoms related to progressive dysfunction of skel-
etal and respiratory muscles.1,2
The replacement of myofibrils by glycogen oc-
curs in the muscle tissue, resulting in loss of contrac-
tile capacity of muscle, hypotonia and in some cases,
hard consistency on touch due to the underlying mus-
cle swelling.2,3
The incidence of Pompe disease in infants range
from approximately 1:138,000 live births, but it is usu-
ally fatal within the first year of life. In teenagers, the
incidence of Pompe disease has been estimated to be
1:720,000, whereas the incidence in adults in some
cases is as high as 1:53,000, which shows a large clini-
cal variability. Regardless, the combined incidence of
the Pompe disease has been suggested to be approxi-
mately 1:40,000. In any circumstance, the involvement
of multiple systems leads to progressive weakness and
disability.4,5
There are few studies on clinical and functional
evaluation of patients who developed Pompe disease.
Therefore, the investigation and description of this
syndrome may help improving the understanding of
the symptoms of the disease and contribute to new
therapeutic approaches. Thus, the purpose of this study
is to describe the clinical and functional changes of
the late-onset Pompe disease.
Case Report
The study was approved by the human research
ethics committee of Universidade de Franca – Unifran
(Franca University), under the protocol: Ref: n # 077/
2011.
A 15 year-old female patient was sent to the
Physical Therapy Clinic at Universidade de Franca
(Unifran) due to the presence of progressive scolio-
sis. At the moment of the evaluation, the patient
weighted 35 kilograms, was 1.48 meters tall and her
body mass index (BMI) was 15.98 kg/m2. The pa-
tient’s main complaints were back and leg pain and
difficulty in performing any physical activity due to
fatigue and decreased breathing capacity.
During postural evaluation, the highest involve-
ment was observed in the anterior view: higher right
shoulder, bigger Thales right angle, higher right iliac
crest, valgus knee and ankle. Regarding posterior view,
it was observed bent head and neck to the right, higher
right scapula and a right inclination of the spine. In the
lateral view, it was observed a protrusion of the head
and shoulders, with steepening of the lumbar pelvic
anteversion.
General muscle weakness was observed
throughout the muscle strength test. The tests were
divided into: upper limb, lower limb and trunk. The
lower limb muscles tested were: hip flexors, exten-
sors, abductors and adductors; knee flexors and ex-
tensors; ankle dorsiflexors and plantiflexors. The up-
per limb muscles tested were: shoulder flexors,
extensors, adductors and abductors; elbow flexors and
extensors; wrist flexors and extensors. All tested mus-
cles were classified as grade four of strength. Trunk
muscles which were tested comprised the obliques,
the upper and lower rectus abdominis and extensors
of the spine and all have been classified as regular, as
proposed by Kendall.6 In the retraction test signifi-
cant shortening of the hamstrings, iliopsoas and major
and minor pectoralis were observed.6
The radiographic exam confirmed right convex
thoracic scoliosis, with Coob angle of 50º (Figure 1).
 
Figure 1. X-ray anterior to posterior. Note scoliosis the convex
right angle 50º of Coob.
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Medical clinical evaluation
After physical therapy evaluation, more than just
a change of posture (scoliosis) was observed, and the
patient was forwarded to Hospital das Clínicas,
Faculdade de Medicina de Ribeirão Preto, Univer-
sidade of São Paulo, HC-FMRP-USP (Ribeirão Preto
Medicine School Hospital, University of São Paulo) to
determine genetic causes of this progressive scolio-
sis. In the clinical evaluation by a Neurogenetics team
of the HC-FMRP-USP, a genetic investigation on the
late-onset spinal muscular atrophy was requested, as
well as investigation on the connective tissues disor-
ders and limb-girdle myopathies. The molecular ex-
amination was normal for spinal muscular atrophy,
however, the enzyme assays for alpha-glucosidase
(acid maltase) on filter paper and leukocytes showed
low enzyme activity, which suggested late-onset Pompe
disease (LOPD). In the molecular analysis, the pres-
ence of mutation c.-32-13T > G in the GAA gene
(which encodes the enzyme alpha-glucosidase) was
identified. This mutation is already described in the
literature and associated with cases of late-onset
Pompe disease (LOPD). To confirm the previous find-
ings, we carried out patient’s skin biopsy for fibroblast
culture and subsequent enzymatic assays to investi-
gate the deficiency of acid alpha-glucosidase. This
analysis showed a reduction of the enzymatic activity
(30% of normal values), thus confirming the diagnosis
of the LOPD.
After biochemical and molecular confirmation
of the disease and worsening of the respiratory ca-
pacity of the patient, it was decided to begin the treat-
ment with recombinant enzyme in an attempt to stabi-
lize the patient’s clinical status before other clinical
parameters were affected.
Currently, the patient is under treatment with
recombinant enzyme alpha-glucosidase (Myozyme®),
which is administered fortnightly. Also, the patient has
been regularly monitored by a team of physical thera-
pists at Universidade de Franca - Unifran for muscle
and pulmonary rehabilitation and maintenance of func-
tionality.
Muscle electrical activity evaluation
The muscle activity was captured within the
surface of electromyography (sEMG) using bipolar
differential electrodes with a preamplifier (Gain x 20)
from EMG System do Brasil Ltda.®. The sEMG sig-
nals were filtered using a bandwidth of 20 Hz to 450
Hz and sampled at 1024 Hz. The sEMG electrodes
were placed on the skin over the muscle bellies of the
biceps brachii, the rectus abdominis and the rectus
femoris corresponding to each body segment. After
data collection, the average root means square (RMS)
values of the surface EMG signals were calculated
for all muscles.7-10 The RMS values obtained were
normalized due to the RMS values obtained in the ac-
tivity of maximum voluntary isometric contraction
(MVIC) and multiplied by 100.11
The sEMG signal presented lower values for
the biceps brachii (mean = 24uV - 52%), the rectus
abdominis (mean = 35uV - 45%) and the rectus femo-
ris (mean = 97uV - 47%). The low electrical activity
of the muscle resulted in a lower recruitment of motor
units12, added four points to the level of muscle
strength during the test, what suggested a generalized
muscle weakness10, similar to delayed motor devel-
opment and undernutrition.
Respiratory capacity evaluation
The ventilatory lung evaluation was analyzed
through test and lung function, using the apparatus
microQuark (Cosmed). The value of forced vital ca-
pacity (FVC) was 40.5%, forced expiratory volume
(FEV1) of 38.4%, index Tiffeneau 94.7%, and peak
flow (PF) of 36.3%, which was the best value ob-
tained. The patient complained of fatigue after minor
physical effort, headaches, difficulty breathing and
sleeping, therefore, non-invasive ventilation was intro-
duced during the night (BiPAP Synchrony).
Discussion
Pompe disease involves progressive muscle in-
jury, with proximal muscle weakness, extreme clinical
variability among patients and between different mus-
cle groups of same patient.13 Non-invasive sEMG was
applied as a resource for capturing the myoelectric
signal resulting from the potential action of the muscle
fibers, which occurs before its contraction, to evalu-
ate the electrical activity of muscles during movement,
the synchronization of muscles activation, the inten-
sity and duration of muscle contraction.14
The biceps brachii, the rectus femoris and the
rectus abdominis and the right hemibody were evalu-
ated in this study because these muscles are extremely
important to maintain good posture and execution of
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tasks.15 All signals captured were considered low, with
a slight signal of muscle fatigue. The sEMG signals
for the rectus abdominis and the rectus femoris mus-
cles were lower than the biceps brachii. These low
values are consistent with the observed muscle weak-
ness which was found in the muscle strength test per-
formed and justifies the patient’s difficulty in chang-
ing positions: lying to sitting/standing and in the
execution of moderate physical activity. Also with re-
gard to the electromyography findings, studies show
that typical muscle weakness and hypotonia are more
severe in lower limbs than in upper limbs. Subsequently,
the involvement of the trunk muscles (postural changes)
was noticed although not all the areas were affected
in the same way. Some patients have unsteady gait
and occasionally walk on tiptoe.1
According to the literature, muscle weakness
is due to affected muscle or motor neurons of the ven-
tral horn, similar to what happens with the skeletal
muscle phenotype in cases of spinal muscle atrophy.
In teenagers and adult forms, the skeletal muscle in-
volvement prevails, often similar to what was seen in
girdle muscular dystrophies. In addition, histological
examination of biopsy shows that the skeletal muscle
fibers exhibit empty spaces which correspond with the
deposits of vacuolar glycogen dissolved during the proc-
ess, and complete distortion of the architecture of the
fibers, supporting the findings of Schoser et al. in
2007.16
Histopathological diagnosis of teenager’s Pompe
disease (glycogen storage disease type II) can be done
through a study of histoenzymology and electron
microscopy of muscle biopsies. Frozen sections of the
muscle stained with hematoxylin and eosin showed a
variation in the diameter of the muscle fibers, the in-
ternalization of nucleic and cytoplasmic vacuoles with
the technique of PAS and PAS with diastasis diges-
tion seems to retain intracytoplasmic glycogen.17
Mainly, in this disease, there is no presence of fibrosis
when staining by the Masson trichrome method, and
intranuclear hiperglicogenose is not observed.18 The
main feature of it is the increase of the acid phos-
phatase activity, with excessive lysosomal material.19
The ultrastructural study revealed a sharp in-
crease in the amount of glycogen, which occupies a
large volume of the myofiber. This glycogen may be
inside vacuoles limited by membranes or may be free
in the cytoplasm. The large accumulation of glycogen
leads to the reduction of contractile myofibrils and in
some cases it can reduce the muscle fiber to an enor-
mous amount of glycogen limited by sarcolemma.20
Regarding the ventilatory capacity reduction that
results in pulmonary restriction can be a consequence
of its own muscle weakness and biomechanical al-
teration of the chest, due to the presence of scoliosis.
The percentage of patients with Pompe disease who
have some lung disfunction is high, reaching 75% of
adults and 59% of children.14 According to the “Ameri-
can College of Chest Physicians” (ACCP), the intro-
duction of non-invasive ventilatory support in patients
with restrictive lung frames leading to neuromuscular
disease should be considered in the presence of symp-
toms such as fatigue, dyspnea, morning headaches,
associated with at least one of the following functional
changes: (i) PaCO2 ³ 45 mmHg; (ii) nocturnal oxime-
try showing oxygen saturation £ 88% for five con-
secutive minutes; (iii) maximal inspiratory pressure
< 60 cm H2O or FVC < 50% predicted.14 Following
these criteria, the use of non-invasive ventilation
(BiPAP) was prescribed for the patient and in some
cases, this may progress to the invasive ventilation
method.
The presence of scoliosis is relatively common
in patients with Pompe disease. In a similar study con-
ducted by van der Beek et al. in 201121, it was ob-
served that the percentage of patients with scoliosis
varied according to age, being more common in chil-
dren (47%) when compared to adults (28%). The sco-
liosis of the patient studied is considered serious, re-
quiring surgical intervention in order to correct spinal
curvature. However, as the patient is reaching the end
of the growth phase and is in enzyme replacement
treatment, a conservative treatment was considered,
using a brace and physical therapy intervention with
postural exercises.
This case showed that Pompe disease induced
important clinical and functional, as well as metabolic
changes, decreased strength and muscle action po-
tential, biomechanical changes in the spine and changes
in respiratory capacity. Furthermore, this case illus-
trates the importance of adequate physical therapy
evaluation as it can be the starting point of investiga-
tion of serious conditions such as the present case of
LOPD, as well as the multidisciplinary approach, gath-
ering the physical therapy team and other health pro-
fessionals taking care of the patient.
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RESUMO
Paciente do sexo feminino com 15 anos, apresentou-se na Clínica de Fisioterapia, devido à presença
de escoliose progressiva com ângulo de Coob de 50º pelo Raio-X. Apresentou queixa de dor na coluna
e na cabeça, fraqueza de cintura escapular e pélvica. Na avaliação fisioterapêutica observou-se um
quadro semelhante ao atraso do desenvolvimento motor e desnutrição, com fraqueza muscular gene-
ralizada (grau = 4) observada pelo teste de Kendall. Na função pulmonar a capacidade vital apresentou
com 40,5%. Estudos enzimáticos com dosagem da alfa-glicosidade ácida em papel-filtro e leucócitos
evidenciaram baixa atividade enzimática, sugestivo de forma tardia da doença de Pompe. No estudo
molecular, comprovou-se que a paciente possuía mutação associada à forma tardia da doença; estu-
dos enzimáticos da alfa-glicosidase ácida em fibroblastos cultivados a partir de biópsia de pele eviden-
ciaram redução da atividade enzimática da alfa-glicosidase ácida, confirmando estudos enzimáticos
prévios. Perante os resultados, a doença de Pompe apresentou alterações clínicas e funcionais impor-
tantes como alteração do metabolismo, diminuição de força e do potencial de ação da musculatura,
alterações biomecânicas na coluna e na capacidade respiratória. Adicionalmente, o caso ilustra a
importância da avaliação fisioterapêutica adequada, pois ele pode ser o ponto de partida da investiga-
ção de doenças graves como o presente caso.
Palavras-Chave: Anormalidades Musculoesqueléticas. Doença de Depósito de Glicogênio. Doença de
Depósito de Glicogênio Tipo II. Biomecânica. Escoliose.
